Introducing the European Medical Journal 2.4

CHELMSFORD, U.K. - Nov. 30, 2017 - PRLog -- The team at the European Medical Journal is proud to present the latest edition of their flagship publication EMJ 2.4. This eJournal contains a myriad of cutting-edge, peer-reviewed articles from a range of therapeutic areas, including oncology, hepatology, dermatology, and many more. In the spirit of multidisciplinary collaboration, EMJ hopes that by sharing these varied papers, readers will benefit from the innovation and new data being cultivated from across the medical sphere. At the heart of the eJournal is the enlightening special feature, penned by Prof Theo de Reijke, scrutinising the development and implementation of clinical guidelines and concluding with his thoughts on how the processes to create these key texts could be improved.

Oncologists, in particular, will benefit from the review penned by Puri et al. titled: 'Screening for Pancreatic Cancer: Current Status and Future Directions'. As Puri et al. describe, pancreatic cancer has a higher mortality rate than any of the other cancer types, despite a low number of reported cases. This fascinating review details the current screening process used by physicians, outlining how more thorough screening methodology and procedures "could prevent PC from becoming the second leading cause of cancer-related death in 2030."

Nephrologists and urologists alike will appreciate Flavin et al. and Maoujoud et al.'s captivating articles discussing kidney disease. Discover the currently underestimated challenges posed by chronic kidney disease in low–middle income countries through the lens of Morocco, as well as the technologies needed to address these challenges, such as robotic-assisted laparoscopic techniques. Online now: http://emjreviews.com/journals/european-medical-journal-2-4-2017/

This eJournal showcases a wide range of developments across many therapeutic areas while raising important questions the medical community should continue to reflect upon. Spencer Gore, Director, European Medical Journal, commented: "I am immensely proud to publish this edition of the EMJ, which I am sure will stimulate lively debate across many therapeutic specialties."

-END-

About the European Medical Journal
The European Medical Journal (http://emjreviews.com/) is an independent company that annually produces a collection of open-access medical eJournals covering therapeutic areas such as Respiratory, Gastroenterology, Cardiology, and Urology. By combining editorials from key opinion leaders with concise news coverage from the leading congresses within the medical industry, we aim to deliver first-class insight into ground-breaking changes and advances in medicine. The production of our high-quality, peer-reviewed eJournals, and our collaborations with independent clinical bodies result in a dynamic and contemporary tool with which to assist industry professionals across Europe in progressively developing their performance and efficacy.